TY - JOUR
T1 - Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure
AU - Rauchhaus, Mathias
AU - Koloczek, Veronika
AU - Volk, Hans Dieter
AU - Kemp, Michael
AU - Niebauer, Josef
AU - Francis, Darrel P.
AU - Coats, Andrew J S
AU - Anker, Stefan D.
PY - 2000
Y1 - 2000
N2 - Aims: We studied the clinical and immunological importance of fasting cholesterol, HDL, LDL and triglycerides in patients with chronic heart failure in relation to plasma concentrations of tumor necrosis factor-α (TNFα), soluble TNF receptor-1 and -2 (sTNF-R1 and -R2), and a ratio potentially indicating recent endotoxin bioactivity (soluble [s] CD14/total cholesterol). Methods and results: Fifty-eight stable, non-oedematous patients with established heart failure and 19 controls were studied prospectively. Concentrations of sTNF-R1 and sCD14 were higher in patients than in controls (1238±96 vs. 632±72 pg/ml, P=0.005 and 3401±120 vs. 2775±139 pg/ml, P=0.007, respectively), whereas those of TNFα (9.3±1.1 vs. 6.7±0.6 pg/ml) and sTNF-R2 (2464±145 vs. 1920±303 pg/ml) were not. Cholesterol (5.6±0.1 vs. 5.5±0.2 mmol/l) and LDL (3.5±0.1 vs. 3.6±0.2 mmol/l) were not different (both P>0.75). Patients had lower HDL (1.10±0.04 vs. 1.4±0.06 mmol/l, P=0.0004) and higher triglycerides (2.1±0.1 vs. 1.1±0.1 mmol/l, P=0.0006). Aetiology and the presence of cardiac cachexia did not influence the lipid profile. Correlations in patients: cholesterol vs. TNFα (r=-0.40, P=0.003), vs. sTNF-R1 (r=-0.24, P=0.08), vs. sTNF-R2 (r=-0.29, P2 (P=0.07), NYHA class (P=0.08), aetiology (P=0.14), and age, body wasting, sodium, LVEF, heart rate, and blood pressure (all P>0.20, follow-up 12 months, event rate 26%). Conclusion: Our data supports previous findings that lower, rather than higher cholesterol levels are associated with poor clinical outcome in patients with chronic heart failure. This relationship is unrelated to heart failure aetiology, and suggests that the classic risk profile is not longer relevant in established heart failure. The little-recognised ability of all lipoprotein fractions to bind endotoxin and to serve as natural buffer substances may explain this relationship between lower lipoprotein levels, higher cytokine concentrations and impaired prognosis. Copyright (C) 2000 Elsevier Science Ireland Ltd.
AB - Aims: We studied the clinical and immunological importance of fasting cholesterol, HDL, LDL and triglycerides in patients with chronic heart failure in relation to plasma concentrations of tumor necrosis factor-α (TNFα), soluble TNF receptor-1 and -2 (sTNF-R1 and -R2), and a ratio potentially indicating recent endotoxin bioactivity (soluble [s] CD14/total cholesterol). Methods and results: Fifty-eight stable, non-oedematous patients with established heart failure and 19 controls were studied prospectively. Concentrations of sTNF-R1 and sCD14 were higher in patients than in controls (1238±96 vs. 632±72 pg/ml, P=0.005 and 3401±120 vs. 2775±139 pg/ml, P=0.007, respectively), whereas those of TNFα (9.3±1.1 vs. 6.7±0.6 pg/ml) and sTNF-R2 (2464±145 vs. 1920±303 pg/ml) were not. Cholesterol (5.6±0.1 vs. 5.5±0.2 mmol/l) and LDL (3.5±0.1 vs. 3.6±0.2 mmol/l) were not different (both P>0.75). Patients had lower HDL (1.10±0.04 vs. 1.4±0.06 mmol/l, P=0.0004) and higher triglycerides (2.1±0.1 vs. 1.1±0.1 mmol/l, P=0.0006). Aetiology and the presence of cardiac cachexia did not influence the lipid profile. Correlations in patients: cholesterol vs. TNFα (r=-0.40, P=0.003), vs. sTNF-R1 (r=-0.24, P=0.08), vs. sTNF-R2 (r=-0.29, P2 (P=0.07), NYHA class (P=0.08), aetiology (P=0.14), and age, body wasting, sodium, LVEF, heart rate, and blood pressure (all P>0.20, follow-up 12 months, event rate 26%). Conclusion: Our data supports previous findings that lower, rather than higher cholesterol levels are associated with poor clinical outcome in patients with chronic heart failure. This relationship is unrelated to heart failure aetiology, and suggests that the classic risk profile is not longer relevant in established heart failure. The little-recognised ability of all lipoprotein fractions to bind endotoxin and to serve as natural buffer substances may explain this relationship between lower lipoprotein levels, higher cytokine concentrations and impaired prognosis. Copyright (C) 2000 Elsevier Science Ireland Ltd.
KW - Chronic heart failure
KW - Cytokines
KW - Endotoxin
KW - Immune activation
KW - Lipoproteins
KW - Prognosis
UR - http://www.scopus.com/inward/record.url?scp=0033694601&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033694601&partnerID=8YFLogxK
U2 - 10.1016/S0167-5273(00)00224-2
DO - 10.1016/S0167-5273(00)00224-2
M3 - Article
C2 - 11104867
AN - SCOPUS:0033694601
SN - 0167-5273
VL - 76
SP - 125
EP - 133
JO - International Journal of Cardiology
JF - International Journal of Cardiology
IS - 2-3
ER -